Harry Schein Exclusive Distributor of Point-of-Care Covid-19 Test
April 01 2020 - 7:45AM
Dow Jones News
By Chris Wack
Henry Schein Inc. said Wednesday it will serve as the exclusive
distributor in the U.S. of a second point-of-care rapid test kit
that can detect antibodies associated with Covid-19 in as few as 15
minutes.
The health-care technology company said it is working with
Becton Dickinson & Co. and BioMedomics, a privately held
clinical diagnostics company, to make the test kits available to
health-care professionals.
The BioMedomics test analyzes blood, serum or plasma samples for
the presence of Immunoglobulin M and Immunoglobulin G antibodies
associated with the coronavirus. The test is completed in four
steps. The results can be read in 15 minutes.
The company said it is also a participant in the White House's
Covid-19 Supply Chain Task Force, and has worked with the Strategic
National Stockpile to deliver personal protective equipment to
Covid-19 testing sites, and is working with the Federal Emergency
Management Agency to source and deliver critical supplies
quickly.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
April 01, 2020 07:30 ET (11:30 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Henry Schein (NASDAQ:HSIC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Henry Schein (NASDAQ:HSIC)
Historical Stock Chart
From Apr 2023 to Apr 2024